Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy

Journal of the American College of Cardiology(2021)10.1016/j.jacc.2021.08.044Source: DataRank Database

Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy is a research paper published in Journal of the American College of Cardiology (2021). On theSindex it has a DataRank of 0. It has been cited 151 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access151 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 8.35)OA: greenTopics (32)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Elad Maor ORCID,David Bomze ORCID,Jennifer E. Liu ORCID,Joerg Herrmann ORCID,Joshua Fein ORCID

Live enrichment

PubMed:34711339 PMC:PMC8562317 OpenAlex:https://openalex.org/W3210942732

National Cancer Institute

Grant: P30 CA008748

National Cancer Institute

Grant: RO1-CA 233610

NCI NIH HHS

Grant: R01 CA233610

NIH

FWCI

8.35

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8562317

publisherhttps://api.elsevier.com/content/article/PII:S0735109721060927?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0735109721060927?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jacc.2021.08.044

Fields of Study

CAR-T cell therapy researchChemotherapy-induced cardiotoxicity and mitigationAcute Myocardial Infarction Research

MeSH Terms

Antineoplastic Agents, ImmunologicalBiological ProductsCardiovascular DiseasesHumansLung DiseasesReceptors, Antigen, T-CellUnited StatesUnited States Food and Drug AdministrationImmunotherapy, AdoptiveDrug MonitoringAdverse Drug Reaction Reporting SystemsNeeds AssessmentPharmacovigilanceCardiotoxicity

Keywords

MedicineAdverse Event Reporting SystemChimeric antigen receptorOdds ratioAdverse effectInternal medicinePharmacovigilanceCytokine release syndromeImmunotherapyCancerVenous ThromboembolismCardiac ArrhythmiasCardio-oncologyCardiovascular Adverse EventsChimeric Antigen Receptor T Cell

Sustainable Development Goals

SDG 0: Good health and well-being